Summary
Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo’s private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Source: finance.yahoo.com
Related posts:
These 12 ‘Dividend Aristocrat’ stocks have been the best income compounders over 5 years
Tesla Stock Is Too Cheap. It Should Start Buying Back Its Own Shares.
Protect yourself 'from ugliness': These 3 top stocks have hiked their dividends for at least 25 stra...
Should You Buy the Best-Performing Vanguard Dividend ETF of the Decade?
Bank of America Says These 2 Stocks Could Double Your Money — Here’s Why They Could Rally